Denis O Okumu1, Lucas J Aponte-Collazo1, Brian J Dewar2, Nathan J Cox3, Michael P East1, Katherine Tech2, Ian M McDonald1, Andrey P Tikunov2, Ekhson Holmuhamedov4, Jeffrey M Macdonald2, Lee M Graves5. 1. Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, United States of America; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, United States of America. 2. Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC 27599, United States of America. 3. Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, United States of America. 4. Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Puschino 142292, Russian Federation. 5. Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, United States of America; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, United States of America. Electronic address: lmg@med.unc.edu.
Abstract
BACKGROUND: Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic responses. We previously demonstrated that the imatinib-resistant CML cells (Myl-R) contained elevated Lyn activity and intracellular creatine pools compared to imatinib-sensitive Myl cells. METHODS: Stable isotope metabolic labeling, media creatine depletion, and Na+/K+-ATPase inhibitor experiments were performed to investigate the origin of creatine pools in Myl-R cells. Inhibition and shRNA knockdown were performed to investigate the specific role of Lyn in regulating the Na+/K+-ATPase and creatine uptake. RESULTS: Inhibition of the Na+/K+-ATPase pump (ouabain, digitoxin), depletion of extracellular creatine or inhibition of Lyn kinase (ponatinib, dasatinib), demonstrated that enhanced creatine accumulation in Myl-R cells was dependent on uptake from the growth media. Creatine uptake was independent of the Na+/creatine symporter (SLC6A8) expression or de novo synthesis. Western blot analyses showed that phosphorylation of the Na+/K+-ATPase on Tyr 10 (Y10), a known regulatory phosphorylation site, correlated with Lyn activity. Overexpression of Lyn in HEK293 cells increased Y10 phosphorylation (pY10) of the Na+/K+-ATPase, whereas Lyn inhibition or shRNA knockdown reduced Na+/K+-ATPase pY10 and decreased creatine accumulation in Myl-R cells. Consistent with enhanced uptake in Myl-R cells, cyclocreatine (Ccr), a cytotoxic creatine analog, caused significant loss of viability in Myl-R compared to Myl cells. CONCLUSIONS: These data suggest that Lyn can affect creatine uptake through Lyn-dependent phosphorylation and regulation of the Na+/K+-ATPase pump activity. GENERAL SIGNIFICANCE: These studies identify kinase regulation of the Na+/K+-ATPase as pivotal in regulating creatine uptake and energy metabolism in cells.
BACKGROUND:Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic responses. We previously demonstrated that the imatinib-resistant CML cells (Myl-R) contained elevated Lyn activity and intracellular creatine pools compared to imatinib-sensitive Myl cells. METHODS: Stable isotope metabolic labeling, media creatine depletion, and Na+/K+-ATPase inhibitor experiments were performed to investigate the origin of creatine pools in Myl-R cells. Inhibition and shRNA knockdown were performed to investigate the specific role of Lyn in regulating the Na+/K+-ATPase and creatine uptake. RESULTS: Inhibition of the Na+/K+-ATPase pump (ouabain, digitoxin), depletion of extracellular creatine or inhibition of Lyn kinase (ponatinib, dasatinib), demonstrated that enhanced creatine accumulation in Myl-R cells was dependent on uptake from the growth media. Creatine uptake was independent of the Na+/creatine symporter (SLC6A8) expression or de novo synthesis. Western blot analyses showed that phosphorylation of the Na+/K+-ATPase on Tyr 10 (Y10), a known regulatory phosphorylation site, correlated with Lyn activity. Overexpression of Lyn in HEK293 cells increased Y10 phosphorylation (pY10) of the Na+/K+-ATPase, whereas Lyn inhibition or shRNA knockdown reduced Na+/K+-ATPase pY10 and decreased creatine accumulation in Myl-R cells. Consistent with enhanced uptake in Myl-R cells, cyclocreatine (Ccr), a cytotoxic creatine analog, caused significant loss of viability in Myl-R compared to Myl cells. CONCLUSIONS: These data suggest that Lyn can affect creatine uptake through Lyn-dependent phosphorylation and regulation of the Na+/K+-ATPase pump activity. GENERAL SIGNIFICANCE: These studies identify kinase regulation of the Na+/K+-ATPase as pivotal in regulating creatine uptake and energy metabolism in cells.
Authors: I Sora; J Richman; G Santoro; H Wei; Y Wang; T Vanderah; R Horvath; M Nguyen; S Waite; W R Roeske Journal: Biochem Biophys Res Commun Date: 1994-10-14 Impact factor: 3.575
Authors: J Klawitter; N Anderson; J Klawitter; U Christians; D Leibfritz; S G Eckhardt; N J Serkova Journal: Br J Cancer Date: 2009-03-03 Impact factor: 7.640
Authors: Vusumuzi N Hove; Kenneth Anderson; Elizabeth R Hayden; Kyle Z Pasquariello; Alice A Gibson; Shichen Shen; Jun Qu; Yan Jin; Jeffrey C Miecznikowski; Shuiying Hu; Jason A Sprowl Journal: Mol Pharmacol Date: 2022-04-05 Impact factor: 4.054
Authors: Adrian Post; Daan Kremer; J Casper Swarte; Sara Sokooti; Fabian A Vogelpohl; Dion Groothof; Ido P Kema; Erwin Garcia; Margery A Connelly; Theo Wallimann; Robin P F Dullaart; Casper F M Franssen; Stephan J L Bakker Journal: J Hypertens Date: 2022-02-01 Impact factor: 4.844